Bio-Rad to Participate at the Morgan Stanley 16th Annual Global Healthcare Conference on September 12
Aug. 29, 2018
HERCULES, Calif.--(BUSINESS WIRE)--Aug 29, 2018--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Christine Tsingos, Executive Vice President and CFO, will participate in a fireside chat at the Morgan Stanley 16th Annual Global Healthcare Conference on Wednesday September 12, at 1:40 PM (ET), at The Grand Hyatt New York, New York City.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied research laboratories that include food safety and environmental quality testing. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.1 billion in 2017. For more information, please visit www.bio-rad.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005813/en/
CONTACT: Bio-Rad Laboratories, Inc.
Tina Cuccia, 510-724-7000
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS MEDICAL DEVICES PHARMACEUTICAL GENERAL HEALTH
SOURCE: Bio-Rad Laboratories, Inc.
Copyright Business Wire 2018.
PUB: 08/29/2018 07:27 PM/DISC: 08/29/2018 07:27 PM